Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2017

01-06-2017 | Original Article

Can either oral glucose challenge test or oral glucose tolerance test parameters predict gestational diabetes mellitus?

Authors: Melahat Yildirim, Aydin Kosus, Nermin Kosus, Deniz Hizli, Banu Akcal, Hatice Kosger

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2017

Login to get access

Abstract

This study aims to evaluate the relationship between the glucose challenge test (GCT) levels and any of the oral glucose tolerance test (OGTT) parameters (fasting plasma glucose (FPG), 1-, 2-, or 3-h plasma glucose levels) and their effect on predicting gestational diabetes mellitus (GDM). This analysis was carried out as a retrospective study at Obstetrics and Gynecology Clinic of Turgut Özal University Hospital. Oral GCT were conducted on patients who are at 24–29 weeks’ gestation. The study participants with positive GCT results underwent a 3-h, 100-g OGTT, and the resulting values were evaluated using Carpenter and Coustan diagnostic criteria to determine the gestational glucose tolerance status of patients. The data obtained from both tests (GCT, FPG, 1-, 2-, 3-h OGTT values) were analyzed to observe the effect of each group on predicting GDM. Although all of the GCT and OGTT values were found to be statistically significant (p < 0.001) in determining GDM, the 2-h values of OGTT detected almost all GDM cases with a very high sensitivity level (94.5 %). The 1-h values on the other hand identified 87.6 % of GDM (p < 0.001). The GCT value with the highest sensitivity and specificity for predicting GDM was calculated as 154.50 mg/dl (sensitivity and specificity rates were 79.2 and 72.8 %, respectively). A 2-h OGTT glucose level can detect GDM with 94.5 % sensitivity. This result can guide clinicians to evaluate the patients with GDM.
Literature
1.
go back to reference Metzeger BE, Coustan DR. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 1998;21 Suppl 2:B161–7. Metzeger BE, Coustan DR. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 1998;21 Suppl 2:B161–7.
2.
go back to reference Jimennez MoLeon J, Bueno-Cavanillas A, Luna-Del-Castillo JD, et al. Predictive value of screen for GDM, influence of associated risk factors. Acta Obstet Gynaecol. 2000;79:991–8.CrossRef Jimennez MoLeon J, Bueno-Cavanillas A, Luna-Del-Castillo JD, et al. Predictive value of screen for GDM, influence of associated risk factors. Acta Obstet Gynaecol. 2000;79:991–8.CrossRef
3.
go back to reference Ahkter J, Qureshi R, Rahim F, et al. Diabetes in pregnancy in Pakistani women. Prev Comp İnd South Asian Comm Diabet Med. 1996;13(3):189–91. Ahkter J, Qureshi R, Rahim F, et al. Diabetes in pregnancy in Pakistani women. Prev Comp İnd South Asian Comm Diabet Med. 1996;13(3):189–91.
4.
go back to reference Bancrofti K, Tuffnel GC, Mason GC, et al. A randomised controlled pilot study for the management of gestational impaired glucose tolerance. BJOG. 2000;107:959–63.CrossRef Bancrofti K, Tuffnel GC, Mason GC, et al. A randomised controlled pilot study for the management of gestational impaired glucose tolerance. BJOG. 2000;107:959–63.CrossRef
5.
go back to reference Young C, Kuehl TJ, Sulak PJ, Allen RS. GDM screening in subsequent pregnancy of previously healthy patients. Am J Obstet Gynaecol. 2000;181(4):798–802. Young C, Kuehl TJ, Sulak PJ, Allen RS. GDM screening in subsequent pregnancy of previously healthy patients. Am J Obstet Gynaecol. 2000;181(4):798–802.
6.
go back to reference Dornhost A, Pateson EM, Nicholls JSD, et al. High prevalence of GDM in women from ethnic minority groups. Diabet Med. 1992;9:820–5.CrossRef Dornhost A, Pateson EM, Nicholls JSD, et al. High prevalence of GDM in women from ethnic minority groups. Diabet Med. 1992;9:820–5.CrossRef
7.
go back to reference O’Sulivan JB, Mahan CM, Charles D, et al. Screening criteria for high risk GDM. Am J Obstet Gynaecol. 1973;116:895–6.CrossRef O’Sulivan JB, Mahan CM, Charles D, et al. Screening criteria for high risk GDM. Am J Obstet Gynaecol. 1973;116:895–6.CrossRef
8.
go back to reference Pettitt DJ, Knowler WC, Baird HR, et al. Gestational diabetes: infant and maternal complication of pregnancy in relation to third-trimester glucose tolerance in Pima Indians. Diabetes Care. 1980;3:458–64.CrossRefPubMed Pettitt DJ, Knowler WC, Baird HR, et al. Gestational diabetes: infant and maternal complication of pregnancy in relation to third-trimester glucose tolerance in Pima Indians. Diabetes Care. 1980;3:458–64.CrossRefPubMed
9.
10.
go back to reference Vogel N, Burnand B, Vial Y, Paccaud JRF, Hohlfeld P. Screening for gestational diabetes: variations in guidelines. Eur J Obstetr Gynecol Reprod Biol. 2000;91:29–36.CrossRef Vogel N, Burnand B, Vial Y, Paccaud JRF, Hohlfeld P. Screening for gestational diabetes: variations in guidelines. Eur J Obstetr Gynecol Reprod Biol. 2000;91:29–36.CrossRef
11.
12.
go back to reference WHO 1994. Prevention of diabetes mellitus, WHO Technical Report series 884 WHO 1994. Prevention of diabetes mellitus, WHO Technical Report series 884
13.
go back to reference American College of Obstetricians and Gynecologists: diabetes and pregnancy, Technical Bulletin No. 200, December 1994 American College of Obstetricians and Gynecologists: diabetes and pregnancy, Technical Bulletin No. 200, December 1994
14.
go back to reference Hanna FW, Peters JR. Screening for gestational diabetes: past, present and future. Diabet Med. 2002;19:351–8.CrossRefPubMed Hanna FW, Peters JR. Screening for gestational diabetes: past, present and future. Diabet Med. 2002;19:351–8.CrossRefPubMed
15.
go back to reference American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003;27:88–90. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003;27:88–90.
16.
go back to reference Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–97.CrossRefPubMed Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–97.CrossRefPubMed
17.
go back to reference The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus of the American Diabetes Association TESTING CRITERIA FOR DIAGNOSIS OF DIABETES MELLITUS Diabetes Care 28:S4-S36, 2005 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus of the American Diabetes Association TESTING CRITERIA FOR DIAGNOSIS OF DIABETES MELLITUS Diabetes Care 28:S4-S36, 2005
18.
go back to reference Bonomo M, Gandini ML, Mastropasqua A, Begher C, Valentini U, Faden D, et al. Which cutoff level should be used in screening for glucose intolerance in pregnancy? Definition of screening methods for gestational diabetes study group of the Lombardy Section of the Italian Society of Diabetology. Am J Obstet Gynecol. 1998;179(1):179–85.CrossRefPubMed Bonomo M, Gandini ML, Mastropasqua A, Begher C, Valentini U, Faden D, et al. Which cutoff level should be used in screening for glucose intolerance in pregnancy? Definition of screening methods for gestational diabetes study group of the Lombardy Section of the Italian Society of Diabetology. Am J Obstet Gynecol. 1998;179(1):179–85.CrossRefPubMed
19.
go back to reference Juntarat W, Rueangchainikhom W, Promas S. 50-grams glucose challenge test for screening of gestational diabetes mellitus in high risk pregnancy. J Med Assoc Thai. 2007;90(4):617–23.PubMed Juntarat W, Rueangchainikhom W, Promas S. 50-grams glucose challenge test for screening of gestational diabetes mellitus in high risk pregnancy. J Med Assoc Thai. 2007;90(4):617–23.PubMed
20.
go back to reference Poyhonen-Alho MK, Teramo KA, Kaaja RJ, Hiilesmaa VK. 50 gram oral glucose challenge test combined with risk factor-based screening for gestational diabetes. Eur J Obstet Gynecol Repro Biol. 2005;121:34–8.CrossRef Poyhonen-Alho MK, Teramo KA, Kaaja RJ, Hiilesmaa VK. 50 gram oral glucose challenge test combined with risk factor-based screening for gestational diabetes. Eur J Obstet Gynecol Repro Biol. 2005;121:34–8.CrossRef
21.
go back to reference Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: a population based study. Obstet Gynecol. 1989;73(4):557–61.PubMed Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: a population based study. Obstet Gynecol. 1989;73(4):557–61.PubMed
22.
go back to reference Corrado F, D’Anna R, Cannata ML, Interdonato ML, Pintaudi B, Di Benedetto A. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabet & Metab. 2012;38:458–61.CrossRef Corrado F, D’Anna R, Cannata ML, Interdonato ML, Pintaudi B, Di Benedetto A. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabet & Metab. 2012;38:458–61.CrossRef
Metadata
Title
Can either oral glucose challenge test or oral glucose tolerance test parameters predict gestational diabetes mellitus?
Authors
Melahat Yildirim
Aydin Kosus
Nermin Kosus
Deniz Hizli
Banu Akcal
Hatice Kosger
Publication date
01-06-2017
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2017
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0386-0

Other articles of this Issue 2/2017

International Journal of Diabetes in Developing Countries 2/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.